NTRA
Natera, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$369.39
+0.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 224.03x
- P/S forward
- 17.06x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 29.23x
- Price / sales
- 19.67x
- Price / cash flow
- 233.29x
Enterprise value
- Enterprise value
- $52.4B
- EV / sales
- 19.35x
- EV / EBITDA
- -292.46x
- EV / EBIT
- -180.87x
- Market cap
- $53.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026